Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at Paramount Gold and Silver Corp. (NYSEMKT:PZG), VIVUS, Inc. (NASAQ:VVUS), DURECT Corporation (NASDAQ:DRRX), RF Micro Devices, Inc. (NASDAQ:RFMD)
Paramount Gold and Silver Corp. (NYSEMKT:PZG) opened the session at $0.91, remained amid the day range of $0.88 - $0.93, and closed the session at $0.890. The stock showed a negative performance of -1.90% in previous trading session. The stock gained a volume of 1.11 million shares and the average volume of the stock remained 676,936 shares. Paramount Gold and Silver Corp. (Paramount) is an exploration stage mining company with projects in northern Nevada and Chihuahua, Mexico. Through its wholly owned Mexican subsidiary, Paramount Gold de Mexico S.A. de C.V., the Company owns a 100% interest in the San Miguel property.
Has PZG Found The Bottom and Ready To Move Up? Find Out Here
VIVUS, Inc. (NASAQ:VVUS) traded with volume of 1.94 million shares in the prior session and the average volume of the stock remained 1.65 million shares. The 52 week range of the stock remained $8.00 - $15.62. The stock showed a negative movement of -0.11% and closed its session at $9.16 The market capitalization of the stock remained 931.62 million. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia).
Has VVUS Found The Bottom And Ready To Gain Momentum? Find Out Here
DURECT Corporation (NASDAQ:DRRX) exchanged 1.11 million shares and the average volume remained 597,282 shares. The stock escalated 3.61 % and closed the session at $1.72. The beta of the stock remained 1.56 and the EPS of the stock remained -0.22. The shares outstanding of the stock remained 110.27 million. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms.
Will DRRX Continue To Move Higher? Find Out Here
RF Micro Devices, Inc. (NASDAQ:RFMD) gained volume of 1.91 million shares, while the average volume remained 3.57 million shares. The stock advanced 0.78% and finished the session at $5.20. The EPS of the stock remained -0.04. The one month of the stock was -1.52% and three month trend remained negative -7.8%. RF Micro Devices, Inc. is engaged in the design and manufacture of radio frequency (RF) solutions. The Company offers products that range from single-function components to integrated circuits and multi-chip modules (MCMs). Its ICs include gain blocks, low noise amplifiers (LNAs), power amplifier (Pas), switches, antenna tuners, receivers, transmitters, transceivers, modulators, demodulators, attenuators, switches, frequency synthesizers and VCOs.
Why Should Investors Buy RFMD After The Recent Gain? Just Go Here and Find Out
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)